Evidence map›Paper›PMID 36370454›Full record

ArticleJournal of industrial microbiology & biotechnology2023

De novo Synthesis of 2-phenylethanol from Glucose by Metabolically Engineered Escherichia coli.

Guanglu Wang, Mengyuan Wang, Jinchu Yang, Qian Li, Nianqing Zhu, Lanxi Liu, Xianmei Hu, Xuepeng Yang

Open access · goldAbstract read
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. EngineeringFrontiers in microbiology · 2026
    Review
  3. Chemobiological synthesis of benzene, toluene, ethylbenzene, and xylene from glucose or glycerol.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Guanglu WangSchool of Food and Bioengineering/Collaborative Innovation Center for Food Production and Safety, Zhengzhou University of Light Industry, Zhengzhou, Henan 450000, People's Republic of China.ORCID 0000-0002-9968-3547
Mengyuan WangSchool of Food and Bioengineering/Collaborative Innovation Center for Food Production and Safety, Zhengzhou University of Light Industry, Zhengzhou, Henan 450000, People's Republic of China.
Jinchu YangTechnology Center, China Tobacco Henan Industrial Co. Ltd. Zhengzhou, Henan 450000, People's Republic of China.
Qian LiSchool of Food and Bioengineering/Collaborative Innovation Center for Food Production and Safety, Zhengzhou University of Light Industry, Zhengzhou, Henan 450000, People's Republic of China.
Nianqing ZhuJiangsu Key Laboratory of Chiral Pharmaceuticals Biosynthesis, College of Pharmaceutical Chemistry & Chemical Engineering, Taizhou University, Taizhou, Jiangsu 225300, People's Republic of China.
Lanxi LiuSchool of Food and Bioengineering/Collaborative Innovation Center for Food Production and Safety, Zhengzhou University of Light Industry, Zhengzhou, Henan 450000, People's Republic of China.
Xianmei HuSchool of Food and Bioengineering/Collaborative Innovation Center for Food Production and Safety, Zhengzhou University of Light Industry, Zhengzhou, Henan 450000, People's Republic of China.
Xuepeng YangSchool of Food and Bioengineering/Collaborative Innovation Center for Food Production and Safety, Zhengzhou University of Light Industry, Zhengzhou, Henan 450000, People's Republic of China.ORCID 0000-0003-2923-7629
Zhengzhou University of Light Industry · CNChina Tobacco · CNTaizhou University · CN

Funding

National Natural Science Foundation of China U1904101Science and Technology Department of Henan Province 202 102 310 021
6 · The paper itself

Abstract

2-Phenylethanol (2- PE) is an aromatic alcohol with wide applications, but there is still no efficient microbial cell factory for 2-PE based on Escherichia coli. In this study, we constructed a metabolically engineered E. coli capable of de novo synthesis of 2-PE from glucose. Firstly, the heterologous styrene-derived and Ehrlich pathways were individually constructed in an L-Phe producer. The results showed that the Ehrlich pathway was better suited to the host than the styrene-derived pathway, resulting in a higher 2-PE titer of ∼0.76 ± 0.02 g/L after 72 h of shake flask fermentation. Furthermore, the phenylacetic acid synthase encoded by feaB was deleted to decrease the consumption of 2-phenylacetaldehyde, and the 2-PE titer increased to 1.75 ± 0.08 g/L. As phosphoenolpyruvate (PEP) is an important precursor for L-Phe synthesis, both the crr and pykF genes were knocked out, leading to ∼35% increase of the 2-PE titer, which reached 2.36 ± 0.06 g/L. Finally, a plasmid-free engineered strain was constructed based on the Ehrlich pathway by integrating multiple ARO10 cassettes (encoding phenylpyruvate decarboxylases) and overexpressing the yjgB gene. The engineered strain produced 2.28 ± 0.20 g/L of 2-PE with a yield of 0.076 g/g glucose and productivity of 0.048 g/L/h. To our best knowledge, this is the highest titer and productivity ever reported for the de novo synthesis of 2-PE in E. coli. In a 5-L fermenter, the 2-PE titer reached 2.15 g/L after 32 h of fermentation, suggesting that the strain has the potential to efficiently produce higher 2-PE titers following further fermentation optimization.

Indexed as

Escherichia coli ProteinsPhenylethyl AlcoholAlcohol OxidoreductasesEscherichia coliFermentationGlucoseMetabolic EngineeringStyrenesAlcohol OxidoreductasesEscherichia coli ProteinsGlucosePhenylethyl AlcoholStyrenesYjgB protein, E coli2-PhenylethanolEhrlich pathwayEscherichia coliMetabolic engineeringStrain improvement

Identifiers

PMID36370454
PMCPMC9923381
OpenAlexW4308833298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.